📰 Imaging And News
Imaging And News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Imaging And. Real-time updates on events, politics, business and more.
February 7, 2024
SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innov...
August 8, 2023
– Enrollment continues globally in multiple clinical studies of vepdegestrant , including VERITAC-2 2L Phase 3 trial and study lead-in for the VERITAC-3 1L Phase 3 trial, both in ER+/HER2-...
June 28, 2023
SEATTLE and SAN FRANCISCO, June 28, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need
May 5, 2023
–Multiple vepdegestrant studies enrolling globally, including Phase 1, 2, and 3 studies– – Preliminary data from the Phase 1b combination trial of vepdegestrant + palbociclib... | May 5, 2023
May 1, 2023
/PRNewswire/ -- Quantum Leap Healthcare Collaborative (Quantum Leap) and Athenex, Inc. (Nasdaq: ATNX) will present the findings of the I-SPY 2 TRIAL evaluation...
March 30, 2023
/PRNewswire/ -- Exai Bio today announced a collaboration agreement with Quantum Leap Healthcare Collaborative™ (QLHC) to broaden the use of Exais novel,...
March 21, 2023
/PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant...
October 27, 2022
Delphi Diagnostics™ Inc and Quantum Leap Healthcare Collaborative™ Announce the Inclusion of Delphi's Proprietary Test, SET2,3™, into the Adaptive Randomization Process for the Ongoing I-SPY 2 TRIAL™ - read this article along with other careers information, tips and advice on BioSpace
August 16, 2022
/PRNewswire/ -- ALX Oncology Holdings Inc., ("ALX Oncology") (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47...
August 16, 2022
SOUTH SAN FRANCISCO, Calif., Aug. 16, 2022 /PRNewswire/ -- ALX Oncology Holdings Inc., (ALX Oncology) (Nasdaq: ALXO) a clinical-stage immuno-onc...